Menu ausklappen

Analyses

Standard treatment in patients with tumor diseases

Standard treatment in patients with tumor diseases

Ignoring profound differences between cancers of individual patients all are treated the same.

Standard treatment in patients with tumor diseases

Ignoring profound differences between cancers of individual patients all are treated the same.

Some patients benefit, some patients do not benefit, and other patients experience adverse drug effects, only.

Advantage of precision oncology

Advantage of precision oncology

The genetic composition of individual cancers even of the same histology is not the same. Small differences within cancer cells can have a major influence on the efficacy of a given cancer treatment. Such differences called biomarkers can be the targets for specifically designed drugs. This novel concept for individualized cancer treatment is called precision oncology.

Advantage of precision oncology

The genetic composition of individual cancers even of the same histology is not the same. Small differences within cancer cells can have a major influence on the efficacy of a given cancer treatment. Such differences called biomarkers can be the targets for specifically designed drugs. This novel concept for individualized cancer treatment is called precision oncology.

Each patient benefits from the biomarker-driven therapy.

Panther-Test

PANTHER measures the activity of all human genes (transcriptome). Based on numerous published gene expression signatures, PANTHER provides the treating oncologist with a wealth of valuable information for personalized therapeutic decisions.

Gene Mutation Panels

By Gene Mutation Panels individual patterns of therapeutically relevant mutations in important cancer-related genes are uncovered. Knowledge of a patient’s individual mutational status is indispensable for a personalized precision oncology treatment approach.

Elephant Assay

ELE.PHANT, indispensable for an individualized comprehensive precision oncology treatment, is a unique state-of-the-art assay amalgamating the patient’s transcriptome data (PANTHER) and therapeutically important mutation data derived from Gen Mutation Panels.

zirkulierende Tumor DNA

Circulating Tumor DNA

Circulating tumor DNA (cfDNA) represents an accurate reflection of a tumor’s mutation pattern in the blood plasma. It is mostly used for real-time response monitoring to targeted drug treatment and as a surrogate analysis of a tumor’s mutational status in cases where no tumor tissue is accessible.

CTC circulating tumor cells

Circulating Tumor Cells (CTC)

The test serves to determine how the blood is affected by tumor cells. It allows for a molecular-genetic characterization of the tumor disease (real-time liquid biopsy).

Chemo-/Biopharmaceutical Sensitivity

Using isolated, living tumor cells, this test determines the response to cytotoxic and biopharmaceutical treatments.

We are happy to consult you in finding the right treatment!